PURA Another PR Out! Puration Announces NCM Bi
Post# of 103002
Puration Announces NCM Biotech Founder and Patented Cannabis Extract Inventor, Frederick Ferri, Hospitality Suite Presentation During Southwest Cannabis Conference
DALLAS, TX / ACCESSWIRE / April 6, 2017 / Puration, Inc. (OTC PINK: PURA) today announced that in a private hospitality suite presentation conducted concurrently with the Southwest Cannabis Conference and Expo in Fort Worth Texas, April 22-23, NCM Biotech, Inc. founder, Frederick Ferri will present an overview on the research and trials of specific cannabis extracts from the patented extract process he invented. NCM Biotech exclusively owns U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
NCM Biotech License Of Patent No. 9,199,960 To PURA
PURA and NCM Biotech, Inc. earlier this week announced that NCM Biotech has licensed to PURA the right to utilize NCM Biotech's patented cannabis extraction process to produce cannabis extracts for infusion into recreational, fitness wellness, alternative medicine and beauty products. The license of the process to PURA is the first and only license NCM Biotech has executed.
NCM Biotech Founder Frederick Ferri On Cannabis Extracts
Frederick Ferri: "With strength and dedication, the board and members of NCM Biotech work continuously to increase public awareness of our alternative treatment. NCM Biotech promotes education for patients, the medical community, and policy makers."
Southwest Cannabis Conference and Expo April 22-23
PURA and NCM Biotech are both participating at the upcoming Southwest Cannabis Conference and Expo April 22-23, in Fort Worth, Texas. PURA's EVERx CBD Infused Bottled Sports Water will be featured in both the AmeriCanna Cafe tradeshow booth and in the NCM Biotech booth. Come to the conference to learn more about PURA and NCM and the license agreement announced today. To attend Frederick Ferri's Hospitality Suite Presentation, please email an inquiry to info@purationinc.com.
To learn more about Puration: purationinc.com
To learn more about NCM Biotech: ncmbiotech.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
SOURCE: Puration, Inc.